Better Buy: Gilead Sciences, Inc. vs. Johnson & Johnson
I bought my shares of Johnson & Johnson (NYSE: JNJ) and Gilead Sciences, Inc. (NASDAQ: GILD) long ago, when they were trading far lower than they are today. If I had to choose one to keep and one to let go of, I'd probably pull out what's left of my hair first.
After watching the path both have taken over the past couple of years, though, choosing the best stock to buy at the moment isn't nearly as nerve-racking. The stocks have run in opposite directions: Johnson & Johnson has outpaced the red-hot S&P 500 with a gain of about 40% over the past two years. Gilead Sciences shares have sunk about 29% over the same time frame.
Image source: Getty Images.
Source: Fool.com
Johnson & Johnson Stock
€145.88
-2.130%
The stock is one of the favorites of our community with 42 Buy predictions and 1 Sell predictions.
With a target price of 187 € there is a positive potential of 28.19% for Johnson & Johnson compared to the current price of 145.88 €.
